An anti-carcinoma monoclonal antibody (mAb) NEO-201 can also target and eliminate human immunosuppressive regulatory T cells (Tregs)

被引：0
|
作者：
Tsang, Kwong [1 ]
Fantini, Massimo [2 ]
David, Justin [2 ]
Morelli, M. Maria [3 ]
Annunzata, Christina [3 ]
Arlen, Philip [2 ]
机构：
[1] Precis Biol, NIH, Bethesda, MD USA
[2] Precis Biol Inc, Bethesda, MD USA
[3] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P771
引用
收藏
页数：1
相关论文
共 20 条
  • [1] A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) NEO-201 can also target human granulocytic myeloid-derived suppressor cells (gMDSCs) and regulatory T (Tregs) cells
    Fantini, Massimo
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Y.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] The O-glycan epitope targeting anti-human carcinoma monoclonal antibody (mAb) NEO-201 can also target human regulatory T cells (Tregs)
    Tanaka, Atsushi
    Fantini, Massimo
    Arlen, Philip M.
    Annunziata, Christina M.
    Tsang, Kwong Y.
    Sakaguchi, Shimon
    CANCER RESEARCH, 2024, 84 (06)
  • [3] AN ANTI-CARCINOMA MONOCLONAL ANTIBODY (MAB) NEO-201 CAN ALSO TARGET HUMAN ACUTE MYELOID LEUKEMIA (AML) CELL LINES IN VITRO
    Romano, Alessandra
    Parrinello, Nunziatina
    Marino, Sara
    La Spina, Enrico
    Fantini, Massimo
    Arlen, Philip
    Tsang, Kwong
    Di Raimondo, Francesco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A925 - A925
  • [4] A THERAPEUTIC HUMANIZED ANTI-CARCINOMA MONOCLONAL ANTIBODY (MAB) CAN ALSO IDENTIFY IMMUNOSUPPRESSIVE REGULATORY T (TREGS) CELLS AND DOWN REGULATE TREG-MEDIATED IMMUNOSUPPRESSION
    Tsang, Kwong
    Fantini, Massimo
    Cole, Christopher
    Annunziata, Christina
    Arlen, Philip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A881 - A881
  • [5] A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) can enhance NK activity and target immunosuppressive regulatory T cells
    Fantini, Massimo
    Morelli, Maria Pia
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Y.
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201
    Tsang, Kwong Y.
    Fantini, Massimo
    Zaki, Anjum
    Mavroukakis, Sharon A.
    Morelli, Maria Pia
    Annunziata, Christina M.
    Arlen, Philip M.
    CANCERS, 2022, 14 (20)
  • [7] IDENTIFICATION OF THE O-GLYCAN EPITOPE TARGETED BY AN ANTI-HUMAN CARCINOMA MONOCLONAL ANTIBODY (MAB) NEO-201
    Fantini, Massimo
    Zaki, Anjum
    Mavroukakis, Sharon
    Annunziata, Christina
    Arlen, Philip
    Tsang, Kwong
    Tsang, Kwong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A60 - A60
  • [8] Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells
    Fantini, Massimo
    Tsang, Kwong Y.
    Arlen, Philip M.
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 812 - 829
  • [9] An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells
    Fantini, Massimo
    David, Justin M.
    Wong, Hing C.
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Y.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (03) : 147 - 159
  • [10] ALT-803 enhances antibody-dependent cell-mediated cytotoxicity (ADCC) mediated by NEO-201 against human carcinoma cells
    Fantini, Massimo
    David, Justin M.
    Wong, Hing C.
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Yok
    CANCER RESEARCH, 2018, 78 (13)
12